financetom
Business
financetom
/
Business
/
Texas Instruments Moderates Capital Spending for 2026; Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas Instruments Moderates Capital Spending for 2026; Shares Up Pre-Bell
Aug 21, 2024 7:52 AM

07:33 AM EDT, 08/21/2024 (MT Newswires) -- Texas Instruments ( TXN ) expects to make a minimum of $2 billion in capital expenditures in 2026 depending on revenue that year, executives said Tuesday in a capital management event.

TI is now looking at a range of $2 billion to $5 billion, adjusting its initial target of $5 billion for flexibility in case revenue comes out lower than expected, the company said.

Activist investor Elliott Investment Management, which took up a position in TI in May, commended the chipmaker's move.

"We commend Texas Instruments ( TXN ) on today's capital-allocation update, which re-affirms TI's long-standing commitment to shareholders that long-term growth of free cash flow per share is the company's true north," Elliott Managing Partner Jesse Cohn and Partner Jason Genrich said in a statement.

TI shares were up 2.2% in recent Wednesday premarket activity.

Price: 206.94, Change: +4.40, Percent Change: +2.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...
Looking At McDonald's's Recent Unusual Options Activity
Looking At McDonald's's Recent Unusual Options Activity
Jan 13, 2025
Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...
What's Going On With 22nd Century Group Shares Monday?
What's Going On With 22nd Century Group Shares Monday?
Jan 13, 2025
22nd Century Group, Inc. ( XXII ) stock is moving higher on Monday after the company announced its readiness to support the Food and Drug Administration’s (FDA) proposed standard to mandate reduced nicotine content in cigarettes. What To Know: The proposed standard aligns with the FDA’s long-standing effort to drastically reduce nicotine levels in cigarettes and is consistent with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved